Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): Clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 7, 1996, Pages 2642-2646

  Burgess, J R ^a   Shepherd, J J ^b   Parameswaran, V ^a   Hoffman, L ^a   Greenaway, T M ^a  

^a ROYAL HOBART HOSPITAL   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE; PROLACTIN; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENETIC SCREENING; HUMAN; HYPOPHYSIS DISEASE; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROLACTINOMA; THYROID FUNCTION;

ADENOMA; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TASMANIA;

EID: 0030004004     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.7.2642     Document Type: Article

References (31)

1. Erdheim J. 1903 Zur normalen und pathologischen histologie der glandula thyreoidea, parathyreoidaea und hypophysis. Beitr Pathol Anat. 33:158-236.
2. Ballard HS, Boy F, Hartsock RJ. 1964 Familial multiple endocrine adenomapeptic ulcer complex. Medicine. 43:481-516.
3. Underdahl LO, Woolner LB, Black DM. 1953 Multiple endocrine adenomas: report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved. J Clin Endocrinol Metab. 13:20-47.
4. Bystrom C, Larsson C, Blomberg C, et al. 1990 Localization of the MEN 1 gene to a small region within chromosome 11q13 deletion mapping in tumors. Proc Natl Acad Sci USA. 87:1968-1990.
5. Larsson C, Shepherd J, Nakamura Y, et al. 1992 Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J Clin Invest. 89:1344-1349.
6. Marx SJ, Vinik AI, Santen RJ, Floyd JC, Mills JL, Green J. 1986 Multiple endocrine neoplasia type 1: assessment of laboratory tests to screen for the gene in a large kindred. Medicine. 65:226-241.
7. Oberg K, Skogseid B, Eriksson B. 1989 Multiple endocrine neoplasia type 1 (MEN-1). Acta Oncol. 28:383-387.
8. Skogseid B, Eriksson B, Lundqvist G, et al. 1991 Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab. 73:281-287.
9. Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LD. 1987 Familial multiple endocrine neoplasia type 1: a new look at pathophysiology. Endocr Rev. 8:391-405.
10. Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland. Am J Hum Genet. 54:1060-1066.
11. Gaitan D, Loosen PT, Orth DN. 1993 Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 76:1580-1582.
12. Schimke RN. 1992 Multiple endocrine neoplasias: how many syndromes? Am J Med Genet. 37:75-83.
13. Samaan NA, Ouais S, Ordonez NG, Choksi UA, Sellin RV, Hickey RC. 1989 Multiple endocrine syndrome type 1: clinical, laboratory findings, and management in five families. Cancer. 64:741-752.
14. McCutcheon IE. 1994 Management of individual tumor syndromes - pituitary neoplasia. Endocrinol Metab Clin North Am. 1:37-51.
15. Burgess JR, Shepherd JJ, Greenaway T. 1994 Thyrotrophinomas in multiple endocrine neoplasia type 1 (MEN 1). Aust N Z J Med. 24:740-741.
16. Skogseid B, Rastad J, Oberg K. 1994 Multiple endocrine neoplasia type 1 - clinical features and screening. Endocrinol Metab Clin North Am. 1:1-18.
17. Scheithauer BW, Laws, Jr, ER, Kovacs K, Horvath E, Randall RV, Carney JA. 1987 Pituitary adenomas of the multiple endocrine neoplasia type 1 syndrome. Semin Diagn Pathol. 4:205-211.
18. Rieth KG, Brody SA. 1983 CT of the pituitary gland in multiple endocrine neoplasia type 1 syndrome. AJNR. 4:813-815.
19. Oppenheim DS, Kana AR, Sangha JS, Klibanski A. 1990 Prevalence of alpha-subunit hypersecretion in patients with pituitary tumours: clinically non functioning and somatotroph adenomas. J Clin Endocrinol Metab. 70:859-864.
20. Burgess J, Hoffman L, Greenaway T, Parameswaran V. 1995 Evaluation of high molecular weight immunoreactive prolactin in multiple endocrine neoplasia type 1 (MEN 1). Aust N Z J Med. 25:382 (Abstract).
21. Dornan J, O'Leary JG, Farid NR. 1984 Dopamine control of prolactin secretion in multiple endocrine neoplasia type 1. Clin Invest Med, 7:161-164.
22. Shepherd JJ. 1985 Latent familial multiple endocrine neoplasia in Tasmania. Med J Aust. 142:395-397.
23. Shepherd JJ. 1991 The natural history of multiple endocrine neoplasia type 1. Arch Surg. 126:935-952.
24. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. , Prolactinomas in a large MEN 1 kindred - clinical features and inheritance pattern. J Clin Endocrinol Metab. 81:1841-1845.
25. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. , Somatotrophinomas in multiple endocrine neoplasia type. 1 - A review of clinical phenotype and IGF-1 levels in a large MEN 1 kindred. Am J Med. In press.
26. Turpin G, Baudin E, Kujas M, De Gennes JL. 1991 Uncommon endocrine polyadenomatosis associating parathyroid adenoma and gonadotrophic pituitary adenoma. A variety of multiple endocrine neoplasm type 1? Presse Med. 20:2266.
27. Costello RT. 1936 Subclinical adenoma of the pituitary gland. Am J Pathol. 12:205-215.
28. Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K. 1981 Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med. 304:156-158.
29. Oberg K, Walinder O, Bostrom H, Lundqvist G. 1982 Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type 1. Am J Med. 73:619-630.
30. Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A. 1989 The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab. 68:412-418.
31. Molitch ME, Elton RL, Blackwell RE, et al. 1985 Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab. 60:698-705.